| Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. A Gasbarrini, GR Corazza, G Gasbarrini, M Montalto, M Di Stefano, ... Alimentary pharmacology & therapeutics 29, 1-49, 2009 | 553 | 2009 |
| Gut–liver axis: the impact of gut microbiota on non alcoholic fatty liver disease D Compare, P Coccoli, A Rocco, OM Nardone, S De Maria, M Cartenì, ... Nutrition, Metabolism and Cardiovascular Diseases 22 (6), 471-476, 2012 | 519 | 2012 |
| Heavy metals in coastal water systems. A case study from the northwestern Gulf of Thailand P Censi, SE Spoto, F Saiano, M Sprovieri, S Mazzola, G Nardone, ... Chemosphere 64 (7), 1167-1176, 2006 | 428 | 2006 |
| Alcoholic disease: liver and beyond A Rocco, D Compare, D Angrisani, MS Zamparelli, G Nardone World journal of gastroenterology: WJG 20 (40), 14652, 2014 | 293 | 2014 |
| Explaining consumer purchase behavior for organic milk: Including trust and green self-identity within the theory of planned behavior V Carfora, C Cavallo, D Caso, T Del Giudice, B De Devitiis, R Viscecchia, ... Food Quality and Preference 76, 1-9, 2019 | 290 | 2019 |
| Coeliac disease and unfavourable outcome of pregnancy P Martinelli, R Troncone, F Paparo, P Torre, E Trapanese, C Fasano, ... Gut 46 (3), 332-335, 2000 | 268 | 2000 |
| The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? G Nardone, D Compare United European gastroenterology journal 3 (3), 255-260, 2015 | 265 | 2015 |
| Emerging trends in European food, diets and food industry FG Santeramo, D Carlucci, B De Devitiis, A Seccia, A Stasi, R Viscecchia, ... Food Research International 104, 39-47, 2018 | 258 | 2018 |
| Risk factors in gastric cancer. D Compare, A Rocco, G Nardone European Review for Medical & Pharmacological Sciences 14 (4), 2010 | 248 | 2010 |
| Consumers’ acceptance and preferences for nutrition-modified and functional dairy products: A systematic review F Bimbo, A Bonanno, G Nocella, R Viscecchia, G Nardone, B De Devitiis, ... Appetite 113, 141-154, 2017 | 234 | 2017 |
| Effect of Helicobacter pyloriinfection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis G Nardone, S Staibano, A Rocco, E Mezza, FP D’Armiento, L Insabato, ... Gut 44 (6), 789-799, 1999 | 233 | 1999 |
| Social Capital in the LEADER Initiative: a methodological approach G Nardone, R Sisto, A Lopolito Journal of Rural Studies 26 (1), 63-72, 2010 | 212 | 2010 |
| Helicobacter pylori and molecular events in precancerous gastric lesions G Nardone, A Rocco, P Malfertheiner Alimentary pharmacology & therapeutics 20 (3), 261-270, 2004 | 211 | 2004 |
| The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract Nardone, Rocco, Balzano, Budillon Alimentary pharmacology & therapeutics 13 (11), 1429-1436, 1999 | 203 | 1999 |
| Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial M Romano, A Cuomo, AG Gravina, A Miranda, MR Iovene, A Tiso, M Sica, ... Gut 59 (11), 1465-1470, 2010 | 198 | 2010 |
| Neuromarketing empirical approaches and food choice: A systematic review A Stasi, G Songa, M Mauri, A Ciceri, F Diotallevi, G Nardone, V Russo Food research international 108, 650-664, 2018 | 191 | 2018 |
| Effects of long‐term PPI treatment on producing bowel symptoms and SIBO D Compare, L Pica, A Rocco, F De Giorgi, R Cuomo, G Sarnelli, ... European journal of clinical investigation 41 (4), 380-386, 2011 | 165 | 2011 |
| Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome M Henström, L Diekmann, F Bonfiglio, F Hadizadeh, EM Kuech, ... Gut 67 (2), 263-270, 2018 | 160 | 2018 |
| Loss-of-function of the voltage-gated sodium channel NaV1. 5 (channelopathies) in patients with irritable bowel syndrome A Beyder, A Mazzone, PR Strege, DJ Tester, YA Saito, CE Bernard, ... Gastroenterology 146 (7), 1659-1668, 2014 | 159 | 2014 |
| Expression of COX‐2, mPGE‐synthase1, MDR‐1 (P‐gp), and Bcl‐xL: a molecular pathway of H pylori‐related gastric carcinogenesis G Nardone, A Rocco, D Vaira, S Staibano, A Budillon, F Tatangelo, ... The Journal of pathology 202 (3), 305-312, 2004 | 142 | 2004 |
